NO20010119D0 - Preparater omfattende GABA-analoger og kaffein - Google Patents

Preparater omfattende GABA-analoger og kaffein

Info

Publication number
NO20010119D0
NO20010119D0 NO20010119A NO20010119A NO20010119D0 NO 20010119 D0 NO20010119 D0 NO 20010119D0 NO 20010119 A NO20010119 A NO 20010119A NO 20010119 A NO20010119 A NO 20010119A NO 20010119 D0 NO20010119 D0 NO 20010119D0
Authority
NO
Norway
Prior art keywords
caffeine
preparations
gaba analogues
gaba
analogues
Prior art date
Application number
NO20010119A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010119L (no
Inventor
Leslie Magnus-Miller
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20010119L publication Critical patent/NO20010119L/no
Publication of NO20010119D0 publication Critical patent/NO20010119D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010119A 1998-07-09 2001-01-08 Preparater omfattende GABA-analoger og kaffein NO20010119D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9213198P 1998-07-09 1998-07-09
PCT/US1999/013670 WO2000002562A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Publications (2)

Publication Number Publication Date
NO20010119L NO20010119L (no) 2001-01-08
NO20010119D0 true NO20010119D0 (no) 2001-01-08

Family

ID=22231777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010119A NO20010119D0 (no) 1998-07-09 2001-01-08 Preparater omfattende GABA-analoger og kaffein

Country Status (13)

Country Link
US (1) US6326374B1 (enExample)
EP (1) EP1094817A1 (enExample)
JP (1) JP2002520286A (enExample)
KR (1) KR20010071777A (enExample)
AU (1) AU772156B2 (enExample)
BR (1) BR9911917A (enExample)
CA (1) CA2332915C (enExample)
ID (1) ID28277A (enExample)
NO (1) NO20010119D0 (enExample)
NZ (1) NZ508490A (enExample)
PL (1) PL345340A1 (enExample)
WO (1) WO2000002562A1 (enExample)
ZA (1) ZA200007168B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934061B3 (en) 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
AU4334900A (en) * 1999-04-09 2000-11-14 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CN1274306C (zh) 2001-09-03 2006-09-13 纽朗制药有限公司 包含加巴喷丁或其类似物和α-氨基酰胺的药物组合物及其止痛应用
PT1727620E (pt) * 2004-03-12 2007-11-05 Warner Lambert Co Ligandos de biofosfina c1-simétricos e a sua utilização na síntese assimétrica da pregabalina
DE602005009161D1 (de) * 2004-04-01 2008-10-02 Warner Lambert Co Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese
CN1972904B (zh) * 2004-06-21 2011-02-02 沃尼尔·朗伯有限责任公司 普瑞巴林和相关化合物的制备
RS51411B (sr) * 2004-09-10 2011-02-28 Newron Pharmaceuticals S.P.A. Upotreba (r)-(halobenziloksi) benzilamino-propanamida kao selektivnih modulatora natrijumovih i/ili kalcijumovih kanala
IN266803B (enExample) 2005-12-22 2015-06-03 Newron Pharm Spa
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
CH699327B1 (de) 2007-02-14 2010-03-15 Oerlikon Heberlein Temco Wattw Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden.
EP2184986A4 (en) 2007-08-06 2010-12-15 Trinity Lab Inc PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC PAIN AND PAIN RELATING TO NEUROPATHY
SG157299A1 (en) 2008-05-09 2009-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
US20100190752A1 (en) * 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5248678A (en) * 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
EP0717624A1 (en) 1993-09-07 1996-06-26 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
US5443838A (en) 1993-09-15 1995-08-22 Koenig, Jr.; Steven M. Nutritional supplementation system
DK0888286T3 (da) * 1996-03-14 2002-02-18 Warner Lambert Co Nye substituerede cykliske aminosyrer som farmaceutiske midler
DE69733081T2 (de) 1996-08-23 2006-05-11 Endo Pharmaceuticals Inc. (n.d.Ges.d. Staates Delaware) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
NZ334898A (en) 1996-10-23 2000-09-29 Warner Lambert Co Substituted gamma aminobutyric acids as pharamceutical agents
WO1999012537A1 (en) * 1997-09-08 1999-03-18 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same

Also Published As

Publication number Publication date
BR9911917A (pt) 2001-03-27
WO2000002562A1 (en) 2000-01-20
AU772156B2 (en) 2004-04-08
CA2332915A1 (en) 2000-01-20
ID28277A (id) 2001-05-10
NZ508490A (en) 2003-08-29
NO20010119L (no) 2001-01-08
ZA200007168B (en) 2002-03-04
JP2002520286A (ja) 2002-07-09
EP1094817A1 (en) 2001-05-02
US6326374B1 (en) 2001-12-04
KR20010071777A (ko) 2001-07-31
PL345340A1 (en) 2001-12-17
AU4691099A (en) 2000-02-01
CA2332915C (en) 2006-10-24

Similar Documents

Publication Publication Date Title
IS5525A (is) Innúðabúnaður og aðferð
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
IS5744A (is) Nýjar 3-arýl-própíónsýruafleiður og -hliðstæður
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20000700L (no) Interleukin-18-proteiner samt fremstilling og anvendelse derav
NO991151D0 (no) Forbindelse og anvendelse derav
NO972911D0 (no) Stabiliserte ribozym-analoger
ITMI982280A0 (it) Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
NO20000943D0 (no) 5-alkyl-2-arylaminofenyleddiksyrer og derivater
NO991150L (no) Pyrazolopyrimidiner og pyrazolotriaziner
DE69826944D1 (de) Konsensus-Phytasen
NO20010119L (no) Preparater omfattende GABA-analoger og kaffein
NO994009D0 (no) Gensekvensator og metoder
DK1015434T3 (da) Ny pyrimidin-4-on og pyrimidin-4-thion som fungicid
ATE266383T1 (de) Dermatologische zubereitungen
NO995324L (no) Baerer for gjenstander og emne for denne
NO20000057L (no) Kjernerør
NO993467D0 (no) Granuler som innbefatter klavulanat og en eller flere eksipienter
NO993731D0 (no) Pyrrolopyrazolopyrimidin-forbindelse og medisin omfattende denne
DE59707298D1 (de) Desodorierende zubereitungen
ITTV970086A0 (it) Struttura di pattino
ZA981419B (en) Arylsulfonamides and analogues
DK0929577T3 (da) Stabiliserede proteinholdige protease-inhibitorer og varianter deraf
ATE246494T1 (de) Brausezubereitungen
DK0826679T3 (da) Naphthylforbindelser og -præparater